

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 9.64937250 |
| 2 | urate metabolic process (GO:0046415) | 9.46263465 |
| 3 | aminoglycoside antibiotic metabolic process (GO:0030647) | 9.07347714 |
| 4 | drug transport (GO:0015893) | 7.75697793 |
| 5 | organic cation transport (GO:0015695) | 7.08278349 |
| 6 | exogenous drug catabolic process (GO:0042738) | 7.03180069 |
| 7 | phosphate ion transport (GO:0006817) | 6.73721671 |
| 8 | drug catabolic process (GO:0042737) | 6.68590170 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.77103851 |
| 10 | quaternary ammonium group transport (GO:0015697) | 5.66624008 |
| 11 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.61349706 |
| 12 | phosphate ion transmembrane transport (GO:0035435) | 5.58164839 |
| 13 | behavioral response to nicotine (GO:0035095) | 5.41944638 |
| 14 | response to pheromone (GO:0019236) | 5.35541469 |
| 15 | lysine metabolic process (GO:0006553) | 5.31706272 |
| 16 | lysine catabolic process (GO:0006554) | 5.31706272 |
| 17 | glutathione biosynthetic process (GO:0006750) | 5.04817444 |
| 18 | central nervous system myelination (GO:0022010) | 4.88945292 |
| 19 | axon ensheathment in central nervous system (GO:0032291) | 4.88945292 |
| 20 | L-phenylalanine catabolic process (GO:0006559) | 4.87852987 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.87852987 |
| 22 | cysteine metabolic process (GO:0006534) | 4.85886855 |
| 23 | response to mercury ion (GO:0046689) | 4.85285272 |
| 24 | metanephric nephron tubule development (GO:0072234) | 4.80347784 |
| 25 | metanephric tubule development (GO:0072170) | 4.80347784 |
| 26 | short-chain fatty acid metabolic process (GO:0046459) | 4.79074675 |
| 27 | excretion (GO:0007588) | 4.77169290 |
| 28 | trivalent inorganic anion homeostasis (GO:0072506) | 4.57975763 |
| 29 | phosphate ion homeostasis (GO:0055062) | 4.57975763 |
| 30 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.55268298 |
| 31 | L-phenylalanine metabolic process (GO:0006558) | 4.55268298 |
| 32 | toxin transport (GO:1901998) | 4.48458516 |
| 33 | behavioral response to ethanol (GO:0048149) | 4.40581716 |
| 34 | metanephric nephron epithelium development (GO:0072243) | 4.38786833 |
| 35 | branched-chain amino acid metabolic process (GO:0009081) | 4.34593439 |
| 36 | sodium-independent organic anion transport (GO:0043252) | 4.33404037 |
| 37 | peptide biosynthetic process (GO:0043043) | 4.32069993 |
| 38 | aspartate family amino acid catabolic process (GO:0009068) | 4.26213151 |
| 39 | renal absorption (GO:0070293) | 4.20689342 |
| 40 | vitamin D metabolic process (GO:0042359) | 4.13806366 |
| 41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.07608488 |
| 42 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.07400294 |
| 43 | metanephric epithelium development (GO:0072207) | 4.07320736 |
| 44 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.05309488 |
| 45 | aromatic amino acid family catabolic process (GO:0009074) | 4.00910787 |
| 46 | opioid receptor signaling pathway (GO:0038003) | 3.94109507 |
| 47 | hindbrain development (GO:0030902) | 3.91323133 |
| 48 | nephron tubule development (GO:0072080) | 3.88018924 |
| 49 | tricarboxylic acid metabolic process (GO:0072350) | 3.87427751 |
| 50 | oligosaccharide catabolic process (GO:0009313) | 3.85119247 |
| 51 | glycoside metabolic process (GO:0016137) | 3.81758266 |
| 52 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.77516984 |
| 53 | branched-chain amino acid catabolic process (GO:0009083) | 3.73887219 |
| 54 | fucose catabolic process (GO:0019317) | 3.73782634 |
| 55 | L-fucose metabolic process (GO:0042354) | 3.73782634 |
| 56 | L-fucose catabolic process (GO:0042355) | 3.73782634 |
| 57 | response to lead ion (GO:0010288) | 3.73130803 |
| 58 | amino-acid betaine transport (GO:0015838) | 3.70488729 |
| 59 | carnitine transport (GO:0015879) | 3.70488729 |
| 60 | cellular modified amino acid catabolic process (GO:0042219) | 3.66419590 |
| 61 | response to phenylpropanoid (GO:0080184) | 3.63572546 |
| 62 | epithelial cilium movement (GO:0003351) | 3.59062324 |
| 63 | polyol transport (GO:0015791) | 3.57423921 |
| 64 | proline metabolic process (GO:0006560) | 3.55314903 |
| 65 | piRNA metabolic process (GO:0034587) | 3.54824915 |
| 66 | serine family amino acid metabolic process (GO:0009069) | 3.49292870 |
| 67 | DNA deamination (GO:0045006) | 3.47326736 |
| 68 | glutathione metabolic process (GO:0006749) | 3.45102714 |
| 69 | neuronal action potential (GO:0019228) | 3.44739951 |
| 70 | fatty acid beta-oxidation (GO:0006635) | 3.41479768 |
| 71 | neural tube formation (GO:0001841) | 3.40952169 |
| 72 | renal tubule development (GO:0061326) | 3.40831466 |
| 73 | glutathione derivative biosynthetic process (GO:1901687) | 3.40648251 |
| 74 | glutathione derivative metabolic process (GO:1901685) | 3.40648251 |
| 75 | adult feeding behavior (GO:0008343) | 3.40343504 |
| 76 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.39174818 |
| 77 | NADH dehydrogenase complex assembly (GO:0010257) | 3.39174818 |
| 78 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.39174818 |
| 79 | modified amino acid transport (GO:0072337) | 3.37863675 |
| 80 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.37017285 |
| 81 | acetyl-CoA metabolic process (GO:0006084) | 3.33907644 |
| 82 | nephron epithelium development (GO:0072009) | 3.33523387 |
| 83 | cellular ketone body metabolic process (GO:0046950) | 3.33435973 |
| 84 | indole-containing compound catabolic process (GO:0042436) | 3.31121151 |
| 85 | indolalkylamine catabolic process (GO:0046218) | 3.31121151 |
| 86 | tryptophan catabolic process (GO:0006569) | 3.31121151 |
| 87 | serine family amino acid catabolic process (GO:0009071) | 3.30586575 |
| 88 | negative regulation of telomere maintenance (GO:0032205) | 3.29531938 |
| 89 | cornea development in camera-type eye (GO:0061303) | 3.25145625 |
| 90 | homocysteine metabolic process (GO:0050667) | 3.24486462 |
| 91 | protein complex biogenesis (GO:0070271) | 3.23916283 |
| 92 | cellular response to ATP (GO:0071318) | 3.18093838 |
| 93 | cilium morphogenesis (GO:0060271) | 3.14211207 |
| 94 | tryptophan metabolic process (GO:0006568) | 3.14147281 |
| 95 | fatty acid oxidation (GO:0019395) | 3.11034908 |
| 96 | amino-acid betaine metabolic process (GO:0006577) | 3.09887718 |
| 97 | regulation of action potential (GO:0098900) | 3.09829207 |
| 98 | dopamine biosynthetic process (GO:0042416) | 3.08434618 |
| 99 | lipid oxidation (GO:0034440) | 3.06032080 |
| 100 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.05531172 |
| 101 | somite development (GO:0061053) | 3.05118131 |
| 102 | drug metabolic process (GO:0017144) | 3.03982420 |
| 103 | resolution of meiotic recombination intermediates (GO:0000712) | 3.03783702 |
| 104 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.03034217 |
| 105 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.02327914 |
| 106 | rRNA catabolic process (GO:0016075) | 3.02025520 |
| 107 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.99239081 |
| 108 | gamma-aminobutyric acid transport (GO:0015812) | 2.97755435 |
| 109 | myelin maintenance (GO:0043217) | 2.97449921 |
| 110 | valine metabolic process (GO:0006573) | 2.97361205 |
| 111 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.96649971 |
| 112 | replication fork processing (GO:0031297) | 2.96285691 |
| 113 | detection of light stimulus involved in visual perception (GO:0050908) | 2.95977451 |
| 114 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.95977451 |
| 115 | neurotransmitter biosynthetic process (GO:0042136) | 2.94847993 |
| 116 | cellular amino acid catabolic process (GO:0009063) | 2.94138562 |
| 117 | serine family amino acid biosynthetic process (GO:0009070) | 2.93798036 |
| 118 | fructose metabolic process (GO:0006000) | 2.92766261 |
| 119 | regulation of telomere maintenance (GO:0032204) | 2.92678314 |
| 120 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.92588972 |
| 121 | prenylation (GO:0097354) | 2.92516705 |
| 122 | protein prenylation (GO:0018342) | 2.92516705 |
| 123 | fatty acid catabolic process (GO:0009062) | 2.89913419 |
| 124 | aldehyde catabolic process (GO:0046185) | 2.89846616 |
| 125 | ketone body metabolic process (GO:1902224) | 2.88694126 |
| 126 | sodium ion transport (GO:0006814) | 2.85759298 |
| 127 | aromatic amino acid family metabolic process (GO:0009072) | 2.85712886 |
| 128 | platelet dense granule organization (GO:0060155) | 2.84923088 |
| 129 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.84545256 |
| 130 | cilium movement (GO:0003341) | 2.83778789 |
| 131 | polyol catabolic process (GO:0046174) | 2.81141743 |
| 132 | carnitine metabolic process (GO:0009437) | 2.81035437 |
| 133 | alpha-amino acid catabolic process (GO:1901606) | 2.79794450 |
| 134 | L-amino acid import (GO:0043092) | 2.79346780 |
| 135 | nephron epithelium morphogenesis (GO:0072088) | 2.78879795 |
| 136 | nephron tubule morphogenesis (GO:0072078) | 2.78879795 |
| 137 | cobalamin metabolic process (GO:0009235) | 2.78723547 |
| 138 | sulfur compound transport (GO:0072348) | 2.77609666 |
| 139 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.77000560 |
| 140 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.74667508 |
| 141 | indole-containing compound metabolic process (GO:0042430) | 2.74573552 |
| 142 | glutamate metabolic process (GO:0006536) | 2.74240648 |
| 143 | beta-amyloid metabolic process (GO:0050435) | 2.74187928 |
| 144 | glycerol metabolic process (GO:0006071) | 2.73999474 |
| 145 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.73759891 |
| 146 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.73345899 |
| 147 | axoneme assembly (GO:0035082) | 2.72875852 |
| 148 | carboxylic acid catabolic process (GO:0046395) | 2.72359127 |
| 149 | organic acid catabolic process (GO:0016054) | 2.72359127 |
| 150 | regulation of cilium movement (GO:0003352) | 2.72217101 |
| 151 | protein K11-linked deubiquitination (GO:0035871) | 2.71745466 |
| 152 | protein neddylation (GO:0045116) | 2.71586305 |
| 153 | anterograde synaptic vesicle transport (GO:0048490) | 2.69522207 |
| 154 | embryonic epithelial tube formation (GO:0001838) | 2.67420248 |
| 155 | cAMP catabolic process (GO:0006198) | 2.67367213 |
| 156 | neurotransmitter metabolic process (GO:0042133) | 2.67325360 |
| 157 | GPI anchor metabolic process (GO:0006505) | 2.67245861 |
| 158 | neurotransmitter catabolic process (GO:0042135) | 2.66555125 |
| 159 | multicellular organism reproduction (GO:0032504) | 2.66032526 |
| 160 | cell proliferation in forebrain (GO:0021846) | 2.63925586 |
| 161 | rhodopsin mediated signaling pathway (GO:0016056) | 2.63578698 |
| 162 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.63362562 |
| 163 | fucosylation (GO:0036065) | 2.62364535 |
| 164 | nucleobase catabolic process (GO:0046113) | 2.61236216 |
| 165 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.61015501 |
| 166 | cilium organization (GO:0044782) | 2.59552840 |
| 167 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.58455001 |
| 168 | retinal cone cell development (GO:0046549) | 2.57753532 |
| 169 | ubiquinone biosynthetic process (GO:0006744) | 2.57015414 |
| 170 | sulfation (GO:0051923) | 2.55197209 |
| 171 | photoreceptor cell maintenance (GO:0045494) | 2.54745554 |
| 172 | single strand break repair (GO:0000012) | 2.54743197 |
| 173 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.53345107 |
| 174 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.51816604 |
| 175 | meiotic chromosome segregation (GO:0045132) | 2.51113958 |
| 176 | vitamin biosynthetic process (GO:0009110) | 2.50782220 |
| 177 | cilium assembly (GO:0042384) | 2.49944027 |
| 178 | protein-cofactor linkage (GO:0018065) | 2.48817229 |
| 179 | epithelial tube formation (GO:0072175) | 2.47933226 |
| 180 | negative regulation of mast cell activation (GO:0033004) | 2.47555163 |
| 181 | male meiosis I (GO:0007141) | 2.47464264 |
| 182 | kynurenine metabolic process (GO:0070189) | 2.46945152 |
| 183 | regulation of acrosome reaction (GO:0060046) | 2.46154652 |
| 184 | positive regulation of action potential (GO:0045760) | 2.45405396 |
| 185 | adenosine metabolic process (GO:0046085) | 2.43963314 |
| 186 | respiratory chain complex IV assembly (GO:0008535) | 2.42734131 |
| 187 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.42370641 |
| 188 | ncRNA catabolic process (GO:0034661) | 2.40511609 |
| 189 | nonmotile primary cilium assembly (GO:0035058) | 2.39878620 |
| 190 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.39743905 |
| 191 | action potential (GO:0001508) | 2.38871949 |
| 192 | protein polyglutamylation (GO:0018095) | 2.38146165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF274_21170338_ChIP-Seq_K562_Hela | 4.02620732 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.94702444 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 2.44991676 |
| 4 | FUS_26573619_Chip-Seq_HEK293_Human | 2.31837258 |
| 5 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.15048673 |
| 6 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.13308903 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.11212001 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.08625987 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.06212765 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.04792773 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.04301695 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.02131881 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.90375324 |
| 14 | EWS_26573619_Chip-Seq_HEK293_Human | 1.88084177 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.85674115 |
| 16 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.84519126 |
| 17 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83953824 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.82703899 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.82002233 |
| 20 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.78384180 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.78384180 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.78376847 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.77274752 |
| 24 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.72149630 |
| 25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.68048185 |
| 26 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.66258053 |
| 27 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.66258053 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.66094145 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.65146721 |
| 30 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.64178865 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.63476007 |
| 32 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.62157956 |
| 33 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.61505773 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60401773 |
| 35 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.59807023 |
| 36 | AR_25329375_ChIP-Seq_VCAP_Human | 1.58340370 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.57452739 |
| 38 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.56818916 |
| 39 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56385658 |
| 40 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.56385658 |
| 41 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.55114009 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.53767919 |
| 43 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.53532348 |
| 44 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.52836156 |
| 45 | STAT3_23295773_ChIP-Seq_U87_Human | 1.51054239 |
| 46 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.48933044 |
| 47 | TCF4_23295773_ChIP-Seq_U87_Human | 1.48116749 |
| 48 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.47116822 |
| 49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.45261072 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.42843477 |
| 51 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.42205265 |
| 52 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.41963205 |
| 53 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.39458200 |
| 54 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.38983859 |
| 55 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38943910 |
| 56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38254345 |
| 57 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.38242591 |
| 58 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.36556026 |
| 59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.36113345 |
| 60 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.35257688 |
| 61 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.34395656 |
| 62 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.34146237 |
| 63 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.33616667 |
| 64 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.32307241 |
| 65 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.31247342 |
| 66 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.27777787 |
| 67 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.27730797 |
| 68 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.26283956 |
| 69 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.26083777 |
| 70 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25557608 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.25428931 |
| 72 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25274812 |
| 73 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.24677316 |
| 74 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.24631643 |
| 75 | NCOR_22424771_ChIP-Seq_293T_Human | 1.24046951 |
| 76 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.23590317 |
| 77 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.23148744 |
| 78 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.23024275 |
| 79 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.22930793 |
| 80 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.22374118 |
| 81 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.21116647 |
| 82 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.20591902 |
| 83 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.20447320 |
| 84 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.19956233 |
| 85 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.19885144 |
| 86 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19662667 |
| 87 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.19210371 |
| 88 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.19210371 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19110061 |
| 90 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.18572508 |
| 91 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.17175788 |
| 92 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16878347 |
| 93 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.16641692 |
| 94 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15049062 |
| 95 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.13732795 |
| 96 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.13692264 |
| 97 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.13061814 |
| 98 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.12596225 |
| 99 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.12517563 |
| 100 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.12323007 |
| 101 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.11522478 |
| 102 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11157274 |
| 103 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10889795 |
| 104 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10228619 |
| 105 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10064147 |
| 106 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09708394 |
| 107 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09142679 |
| 108 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08588452 |
| 109 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05916329 |
| 110 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05704295 |
| 111 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.05661974 |
| 112 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05584942 |
| 113 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05383443 |
| 114 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05383443 |
| 115 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04786020 |
| 116 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.04782150 |
| 117 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.04583595 |
| 118 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03562240 |
| 119 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03287533 |
| 120 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02975846 |
| 121 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02136658 |
| 122 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01726708 |
| 123 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.01471502 |
| 124 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.01273275 |
| 125 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01256910 |
| 126 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.01217163 |
| 127 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01014387 |
| 128 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01012148 |
| 129 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.00694305 |
| 130 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00534634 |
| 131 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00465794 |
| 132 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99929207 |
| 133 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99218319 |
| 134 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.98967893 |
| 135 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.98784595 |
| 136 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.98736286 |
| 137 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98218500 |
| 138 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98218500 |
| 139 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97963046 |
| 140 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97090036 |
| 141 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.97014363 |
| 142 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96879639 |
| 143 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94458977 |
| 144 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93473612 |
| 145 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.93251054 |
| 146 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.92129391 |
| 147 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.91792033 |
| 148 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91630985 |
| 149 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91368312 |
| 150 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.90607555 |
| 151 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90417491 |
| 152 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.90123785 |
| 153 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89317670 |
| 154 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 0.89258811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 6.63009716 |
| 2 | MP0005360_urolithiasis | 5.83093024 |
| 3 | MP0005332_abnormal_amino_acid | 4.32419432 |
| 4 | MP0004019_abnormal_vitamin_homeostasis | 4.29615494 |
| 5 | MP0003195_calcinosis | 3.64799431 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.54191366 |
| 7 | MP0001765_abnormal_ion_homeostasis | 3.49140368 |
| 8 | MP0009643_abnormal_urine_homeostasis | 3.22773290 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.14316579 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 3.06124960 |
| 11 | MP0000569_abnormal_digit_pigmentation | 2.96262158 |
| 12 | MP0005636_abnormal_mineral_homeostasis | 2.63446436 |
| 13 | MP0004885_abnormal_endolymph | 2.59509860 |
| 14 | MP0005377_hearing/vestibular/ear_phenot | 2.58352344 |
| 15 | MP0003878_abnormal_ear_physiology | 2.58352344 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.56096510 |
| 17 | MP0001958_emphysema | 2.52470963 |
| 18 | MP0002136_abnormal_kidney_physiology | 2.36549078 |
| 19 | MP0000920_abnormal_myelination | 2.26423647 |
| 20 | MP0003646_muscle_fatigue | 2.24074994 |
| 21 | MP0002736_abnormal_nociception_after | 2.17842240 |
| 22 | MP0008877_abnormal_DNA_methylation | 2.17455665 |
| 23 | MP0001501_abnormal_sleep_pattern | 2.13726072 |
| 24 | MP0005174_abnormal_tail_pigmentation | 2.13514429 |
| 25 | MP0001756_abnormal_urination | 2.12849410 |
| 26 | MP0004742_abnormal_vestibular_system | 2.10909517 |
| 27 | MP0003787_abnormal_imprinting | 1.96826815 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.94370806 |
| 29 | MP0001529_abnormal_vocalization | 1.93436940 |
| 30 | MP0004133_heterotaxia | 1.91581486 |
| 31 | MP0008872_abnormal_physiological_respon | 1.88428933 |
| 32 | MP0002638_abnormal_pupillary_reflex | 1.83759576 |
| 33 | MP0002938_white_spotting | 1.80873688 |
| 34 | MP0000427_abnormal_hair_cycle | 1.78683548 |
| 35 | MP0001485_abnormal_pinna_reflex | 1.77133646 |
| 36 | MP0005451_abnormal_body_composition | 1.73282141 |
| 37 | MP0003252_abnormal_bile_duct | 1.73032043 |
| 38 | MP0003283_abnormal_digestive_organ | 1.71299915 |
| 39 | MP0001986_abnormal_taste_sensitivity | 1.70046441 |
| 40 | MP0001661_extended_life_span | 1.69005967 |
| 41 | MP0005085_abnormal_gallbladder_physiolo | 1.68801589 |
| 42 | MP0006292_abnormal_olfactory_placode | 1.56643951 |
| 43 | MP0004147_increased_porphyrin_level | 1.49945096 |
| 44 | MP0002234_abnormal_pharynx_morphology | 1.49815239 |
| 45 | MP0005646_abnormal_pituitary_gland | 1.49119742 |
| 46 | MP0005389_reproductive_system_phenotype | 1.48618287 |
| 47 | MP0005253_abnormal_eye_physiology | 1.47976826 |
| 48 | MP0003136_yellow_coat_color | 1.47151286 |
| 49 | MP0003186_abnormal_redox_activity | 1.45488594 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 1.44650400 |
| 51 | MP0002837_dystrophic_cardiac_calcinosis | 1.41800925 |
| 52 | MP0001919_abnormal_reproductive_system | 1.41422710 |
| 53 | MP0000383_abnormal_hair_follicle | 1.38492120 |
| 54 | MP0003690_abnormal_glial_cell | 1.37943461 |
| 55 | MP0002733_abnormal_thermal_nociception | 1.37736052 |
| 56 | MP0006276_abnormal_autonomic_nervous | 1.37296311 |
| 57 | MP0008058_abnormal_DNA_repair | 1.30964962 |
| 58 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.29570960 |
| 59 | MP0001970_abnormal_pain_threshold | 1.27204164 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.27042673 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.26474965 |
| 62 | MP0004924_abnormal_behavior | 1.22288457 |
| 63 | MP0005386_behavior/neurological_phenoty | 1.22288457 |
| 64 | MP0001293_anophthalmia | 1.21964026 |
| 65 | MP0002160_abnormal_reproductive_system | 1.20116072 |
| 66 | MP0003329_amyloid_beta_deposits | 1.19485892 |
| 67 | MP0000566_synostosis | 1.18654401 |
| 68 | MP0005365_abnormal_bile_salt | 1.18379626 |
| 69 | MP0000538_abnormal_urinary_bladder | 1.18055054 |
| 70 | MP0005187_abnormal_penis_morphology | 1.17376586 |
| 71 | MP0001486_abnormal_startle_reflex | 1.16087108 |
| 72 | MP0002572_abnormal_emotion/affect_behav | 1.15905582 |
| 73 | MP0006072_abnormal_retinal_apoptosis | 1.15458026 |
| 74 | MP0009046_muscle_twitch | 1.14758423 |
| 75 | MP0002734_abnormal_mechanical_nocicepti | 1.14730393 |
| 76 | MP0001963_abnormal_hearing_physiology | 1.13893045 |
| 77 | MP0003718_maternal_effect | 1.12759734 |
| 78 | MP0002557_abnormal_social/conspecific_i | 1.12365060 |
| 79 | MP0008260_abnormal_autophagy | 1.12177144 |
| 80 | MP0002095_abnormal_skin_pigmentation | 1.11544291 |
| 81 | MP0003011_delayed_dark_adaptation | 1.10400871 |
| 82 | MP0004130_abnormal_muscle_cell | 1.09096487 |
| 83 | MP0005647_abnormal_sex_gland | 1.08027312 |
| 84 | MP0000230_abnormal_systemic_arterial | 1.07670134 |
| 85 | MP0005409_darkened_coat_color | 1.06624458 |
| 86 | MP0001324_abnormal_eye_pigmentation | 1.05731300 |
| 87 | MP0003121_genomic_imprinting | 1.05407944 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 1.05005102 |
| 89 | MP0002063_abnormal_learning/memory/cond | 1.04349220 |
| 90 | MP0000015_abnormal_ear_pigmentation | 1.04228985 |
| 91 | MP0004142_abnormal_muscle_tone | 1.03975683 |
| 92 | MP0005075_abnormal_melanosome_morpholog | 1.03437320 |
| 93 | MP0003938_abnormal_ear_development | 1.02967335 |
| 94 | MP0005670_abnormal_white_adipose | 1.02316327 |
| 95 | MP0005195_abnormal_posterior_eye | 1.00326536 |
| 96 | MP0000026_abnormal_inner_ear | 0.96652035 |
| 97 | MP0003937_abnormal_limbs/digits/tail_de | 0.96607898 |
| 98 | MP0003880_abnormal_central_pattern | 0.95984672 |
| 99 | MP0005535_abnormal_body_temperature | 0.95632552 |
| 100 | MP0006035_abnormal_mitochondrial_morpho | 0.94711876 |
| 101 | MP0004270_analgesia | 0.93272051 |
| 102 | MP0002064_seizures | 0.93175787 |
| 103 | MP0005666_abnormal_adipose_tissue | 0.93108912 |
| 104 | MP0002896_abnormal_bone_mineralization | 0.91348404 |
| 105 | MP0003635_abnormal_synaptic_transmissio | 0.90274070 |
| 106 | MP0002229_neurodegeneration | 0.88733320 |
| 107 | MP0003950_abnormal_plasma_membrane | 0.88130933 |
| 108 | MP0002277_abnormal_respiratory_mucosa | 0.87331010 |
| 109 | MP0008775_abnormal_heart_ventricle | 0.85197265 |
| 110 | MP0002168_other_aberrant_phenotype | 0.84922079 |
| 111 | MP0006036_abnormal_mitochondrial_physio | 0.84545356 |
| 112 | MP0000647_abnormal_sebaceous_gland | 0.84034256 |
| 113 | MP0005645_abnormal_hypothalamus_physiol | 0.82700265 |
| 114 | MP0003119_abnormal_digestive_system | 0.81963528 |
| 115 | MP0000049_abnormal_middle_ear | 0.81545389 |
| 116 | MP0002102_abnormal_ear_morphology | 0.81179142 |
| 117 | MP0002909_abnormal_adrenal_gland | 0.80666612 |
| 118 | MP0005391_vision/eye_phenotype | 0.78947359 |
| 119 | MP0002272_abnormal_nervous_system | 0.77830156 |
| 120 | MP0002796_impaired_skin_barrier | 0.77536848 |
| 121 | MP0002098_abnormal_vibrissa_morphology | 0.77097382 |
| 122 | MP0000747_muscle_weakness | 0.76135856 |
| 123 | MP0000762_abnormal_tongue_morphology | 0.75751246 |
| 124 | MP0002067_abnormal_sensory_capabilities | 0.75469619 |
| 125 | MP0001440_abnormal_grooming_behavior | 0.75306404 |
| 126 | MP0003122_maternal_imprinting | 0.75160285 |
| 127 | MP0003634_abnormal_glial_cell | 0.75137156 |
| 128 | MP0003698_abnormal_male_reproductive | 0.74896508 |
| 129 | MP0002254_reproductive_system_inflammat | 0.74753900 |
| 130 | MP0002118_abnormal_lipid_homeostasis | 0.71562592 |
| 131 | MP0003172_abnormal_lysosome_physiology | 0.71417650 |
| 132 | MP0004381_abnormal_hair_follicle | 0.70949114 |
| 133 | MP0005408_hypopigmentation | 0.70610437 |
| 134 | MP0009745_abnormal_behavioral_response | 0.70008233 |
| 135 | MP0003633_abnormal_nervous_system | 0.69040359 |
| 136 | MP0005319_abnormal_enzyme/_coenzyme | 0.68830150 |
| 137 | MP0000778_abnormal_nervous_system | 0.68804342 |
| 138 | MP0001905_abnormal_dopamine_level | 0.66824832 |
| 139 | MP0002928_abnormal_bile_duct | 0.64822886 |
| 140 | MP0005501_abnormal_skin_physiology | 0.62276767 |
| 141 | MP0001664_abnormal_digestion | 0.60874512 |
| 142 | MP0002066_abnormal_motor_capabilities/c | 0.58321911 |
| 143 | MP0003631_nervous_system_phenotype | 0.57584042 |
| 144 | MP0009780_abnormal_chondrocyte_physiolo | 0.57264391 |
| 145 | MP0001764_abnormal_homeostasis | 0.56768537 |
| 146 | MP0002249_abnormal_larynx_morphology | 0.56351496 |
| 147 | MP0005595_abnormal_vascular_smooth | 0.55747273 |
| 148 | MP0001727_abnormal_embryo_implantation | 0.55535786 |
| 149 | MP0000163_abnormal_cartilage_morphology | 0.55168358 |
| 150 | MP0003879_abnormal_hair_cell | 0.54903243 |
| 151 | MP0008961_abnormal_basal_metabolism | 0.54684219 |
| 152 | MP0005551_abnormal_eye_electrophysiolog | 0.54220932 |
| 153 | MP0005165_increased_susceptibility_to | 0.53835026 |
| 154 | MP0002135_abnormal_kidney_morphology | 0.53609986 |
| 155 | MP0002115_abnormal_skeleton_extremities | 0.53483332 |
| 156 | MP0002089_abnormal_postnatal_growth/wei | 0.53367657 |
| 157 | MP0003724_increased_susceptibility_to | 0.52682093 |
| 158 | MP0002069_abnormal_eating/drinking_beha | 0.52649522 |
| 159 | MP0010386_abnormal_urinary_bladder | 0.52640265 |
| 160 | MP0002735_abnormal_chemical_nociception | 0.52261813 |
| 161 | MP0003638_abnormal_response/metabolism_ | 0.51392505 |
| 162 | MP0010678_abnormal_skin_adnexa | 0.50754423 |
| 163 | MP0000631_abnormal_neuroendocrine_gland | 0.49357482 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 7.67202266 |
| 2 | Metabolic alkalosis (HP:0200114) | 7.52206365 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 7.27096430 |
| 4 | Hypomagnesemia (HP:0002917) | 7.03329297 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 6.02555155 |
| 6 | Abnormality of chloride homeostasis (HP:0011422) | 5.96306864 |
| 7 | Polyuria (HP:0000103) | 5.96007901 |
| 8 | Abnormality of magnesium homeostasis (HP:0004921) | 5.78152075 |
| 9 | Gout (HP:0001997) | 5.66523814 |
| 10 | Abnormal urine output (HP:0012590) | 5.51514600 |
| 11 | Abnormality of renal excretion (HP:0011036) | 5.41531353 |
| 12 | Polydipsia (HP:0001959) | 4.93635796 |
| 13 | Abnormal drinking behavior (HP:0030082) | 4.93635796 |
| 14 | Proximal tubulopathy (HP:0000114) | 4.91531754 |
| 15 | Abnormality of renin-angiotensin system (HP:0000847) | 4.72477481 |
| 16 | Alkalosis (HP:0001948) | 4.64973448 |
| 17 | Hyperaldosteronism (HP:0000859) | 4.50191816 |
| 18 | Renal salt wasting (HP:0000127) | 4.44251220 |
| 19 | Tetany (HP:0001281) | 4.42345894 |
| 20 | Increased purine levels (HP:0004368) | 4.04441153 |
| 21 | Hyperuricemia (HP:0002149) | 4.04441153 |
| 22 | Congenital stationary night blindness (HP:0007642) | 4.01662180 |
| 23 | Pancreatic cysts (HP:0001737) | 3.98071490 |
| 24 | Abnormality of midbrain morphology (HP:0002418) | 3.88679734 |
| 25 | Molar tooth sign on MRI (HP:0002419) | 3.88679734 |
| 26 | True hermaphroditism (HP:0010459) | 3.88583263 |
| 27 | Hyperglycinuria (HP:0003108) | 3.81864521 |
| 28 | Generalized aminoaciduria (HP:0002909) | 3.75884829 |
| 29 | Pancreatic fibrosis (HP:0100732) | 3.74483074 |
| 30 | Glycosuria (HP:0003076) | 3.69652113 |
| 31 | Abnormality of urine glucose concentration (HP:0011016) | 3.69652113 |
| 32 | Abnormality of purine metabolism (HP:0004352) | 3.69646386 |
| 33 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.68836764 |
| 34 | Hypercalciuria (HP:0002150) | 3.57266778 |
| 35 | Hypokalemia (HP:0002900) | 3.51419402 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 3.48734769 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.48734769 |
| 38 | Abnormality of alanine metabolism (HP:0010916) | 3.37162839 |
| 39 | Hyperalaninemia (HP:0003348) | 3.37162839 |
| 40 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.37162839 |
| 41 | Nephronophthisis (HP:0000090) | 3.35415495 |
| 42 | Abnormal urine phosphate concentration (HP:0012599) | 3.26782554 |
| 43 | Abnormality of the renal cortex (HP:0011035) | 3.26324846 |
| 44 | Abnormality of potassium homeostasis (HP:0011042) | 3.22912847 |
| 45 | Delayed epiphyseal ossification (HP:0002663) | 3.18621232 |
| 46 | Hyperphosphaturia (HP:0003109) | 3.16220729 |
| 47 | Renal cortical cysts (HP:0000803) | 3.09938121 |
| 48 | Ketoacidosis (HP:0001993) | 3.09639633 |
| 49 | Renal tubular acidosis (HP:0001947) | 3.04855955 |
| 50 | Abnormality of the renal medulla (HP:0100957) | 2.99630515 |
| 51 | Vascular calcification (HP:0004934) | 2.93980615 |
| 52 | Rickets (HP:0002748) | 2.90280638 |
| 53 | Congenital, generalized hypertrichosis (HP:0004540) | 2.88259159 |
| 54 | Thyroid-stimulating hormone excess (HP:0002925) | 2.83475495 |
| 55 | Hypophosphatemia (HP:0002148) | 2.80158464 |
| 56 | Ketosis (HP:0001946) | 2.78689063 |
| 57 | Abnormality of renal resorption (HP:0011038) | 2.77214565 |
| 58 | Nephrocalcinosis (HP:0000121) | 2.75261303 |
| 59 | 3-Methylglutaconic aciduria (HP:0003535) | 2.74841557 |
| 60 | Medial flaring of the eyebrow (HP:0010747) | 2.74348618 |
| 61 | Abnormality of nucleobase metabolism (HP:0010932) | 2.61511499 |
| 62 | Type II lissencephaly (HP:0007260) | 2.60587790 |
| 63 | Cystic liver disease (HP:0006706) | 2.59795351 |
| 64 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.59328585 |
| 65 | Confusion (HP:0001289) | 2.58304798 |
| 66 | Progressive inability to walk (HP:0002505) | 2.56716269 |
| 67 | Cardiovascular calcification (HP:0011915) | 2.56306781 |
| 68 | Enlarged kidneys (HP:0000105) | 2.54103188 |
| 69 | Nephrogenic diabetes insipidus (HP:0009806) | 2.53313767 |
| 70 | Chronic hepatic failure (HP:0100626) | 2.52649835 |
| 71 | Broad-based gait (HP:0002136) | 2.50661347 |
| 72 | Hypophosphatemic rickets (HP:0004912) | 2.50373111 |
| 73 | Inability to walk (HP:0002540) | 2.49963598 |
| 74 | Hyperglycinemia (HP:0002154) | 2.48759505 |
| 75 | Nephrolithiasis (HP:0000787) | 2.48573689 |
| 76 | Vacuolated lymphocytes (HP:0001922) | 2.45806005 |
| 77 | Abnormality of macular pigmentation (HP:0008002) | 2.42103433 |
| 78 | Attenuation of retinal blood vessels (HP:0007843) | 2.40932050 |
| 79 | Lissencephaly (HP:0001339) | 2.40395698 |
| 80 | Large for gestational age (HP:0001520) | 2.39242186 |
| 81 | Intestinal atresia (HP:0011100) | 2.38915108 |
| 82 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.38544278 |
| 83 | Gait imbalance (HP:0002141) | 2.36225278 |
| 84 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.33766836 |
| 85 | Widely patent fontanelles and sutures (HP:0004492) | 2.33055630 |
| 86 | Hydroxyprolinuria (HP:0003080) | 2.31964749 |
| 87 | Abnormality of proline metabolism (HP:0010907) | 2.31964749 |
| 88 | Renal tubular dysfunction (HP:0000124) | 2.29737944 |
| 89 | Decreased central vision (HP:0007663) | 2.25574749 |
| 90 | Dehydration (HP:0001944) | 2.24733226 |
| 91 | Delayed CNS myelination (HP:0002188) | 2.24257010 |
| 92 | Sclerocornea (HP:0000647) | 2.23969876 |
| 93 | Gaze-evoked nystagmus (HP:0000640) | 2.23936603 |
| 94 | Colon cancer (HP:0003003) | 2.22831729 |
| 95 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.21523433 |
| 96 | Methylmalonic aciduria (HP:0012120) | 2.21130460 |
| 97 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.20992590 |
| 98 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.20992590 |
| 99 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.20737823 |
| 100 | Volvulus (HP:0002580) | 2.20562608 |
| 101 | Anencephaly (HP:0002323) | 2.19614714 |
| 102 | Fair hair (HP:0002286) | 2.19387220 |
| 103 | Hyponatremia (HP:0002902) | 2.17792673 |
| 104 | Furrowed tongue (HP:0000221) | 2.17771953 |
| 105 | Congenital primary aphakia (HP:0007707) | 2.16746646 |
| 106 | Metaphyseal dysplasia (HP:0100255) | 2.16710615 |
| 107 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.16664792 |
| 108 | Male pseudohermaphroditism (HP:0000037) | 2.13538513 |
| 109 | Protruding tongue (HP:0010808) | 2.13243584 |
| 110 | Hyperkalemia (HP:0002153) | 2.12285796 |
| 111 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.12184824 |
| 112 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.11323378 |
| 113 | Dicarboxylic aciduria (HP:0003215) | 2.11323378 |
| 114 | Drooling (HP:0002307) | 2.11123836 |
| 115 | Increased corneal curvature (HP:0100692) | 2.10510424 |
| 116 | Keratoconus (HP:0000563) | 2.10510424 |
| 117 | Metabolic acidosis (HP:0001942) | 2.08544174 |
| 118 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.06278456 |
| 119 | Metaphyseal irregularity (HP:0003025) | 2.03275334 |
| 120 | Methylmalonic acidemia (HP:0002912) | 2.03208820 |
| 121 | Hyperventilation (HP:0002883) | 2.03122436 |
| 122 | Abnormality of sodium homeostasis (HP:0010931) | 2.02952576 |
| 123 | Pendular nystagmus (HP:0012043) | 2.02932481 |
| 124 | Focal motor seizures (HP:0011153) | 2.00982689 |
| 125 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.97596057 |
| 126 | Vomiting (HP:0002013) | 1.96738520 |
| 127 | Hypoplasia of the fovea (HP:0007750) | 1.96250366 |
| 128 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.96250366 |
| 129 | Increased CSF lactate (HP:0002490) | 1.96217266 |
| 130 | Partial agenesis of the corpus callosum (HP:0001338) | 1.95266631 |
| 131 | Stomach cancer (HP:0012126) | 1.94998950 |
| 132 | Abnormality of the fovea (HP:0000493) | 1.94832984 |
| 133 | Optic disc pallor (HP:0000543) | 1.93259208 |
| 134 | Abnormal tarsal ossification (HP:0008369) | 1.93245665 |
| 135 | Oligodactyly (hands) (HP:0001180) | 1.93189066 |
| 136 | Generalized hypopigmentation of hair (HP:0011358) | 1.91962731 |
| 137 | Abolished electroretinogram (ERG) (HP:0000550) | 1.91509726 |
| 138 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.91398346 |
| 139 | Absent/shortened dynein arms (HP:0200106) | 1.91398346 |
| 140 | Excessive salivation (HP:0003781) | 1.89264430 |
| 141 | Mitochondrial inheritance (HP:0001427) | 1.89241764 |
| 142 | Hypoplasia of the uterus (HP:0000013) | 1.89138284 |
| 143 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.88412002 |
| 144 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.88412002 |
| 145 | Severe muscular hypotonia (HP:0006829) | 1.86602551 |
| 146 | Abnormal biliary tract physiology (HP:0012439) | 1.86356216 |
| 147 | Bile duct proliferation (HP:0001408) | 1.86356216 |
| 148 | Genetic anticipation (HP:0003743) | 1.86238358 |
| 149 | Axonal loss (HP:0003447) | 1.85973343 |
| 150 | Elevated alkaline phosphatase (HP:0003155) | 1.85910609 |
| 151 | Lethargy (HP:0001254) | 1.85177601 |
| 152 | Hemiparesis (HP:0001269) | 1.85052973 |
| 153 | Absent speech (HP:0001344) | 1.84371839 |
| 154 | Hyperammonemia (HP:0001987) | 1.83546049 |
| 155 | Congenital hepatic fibrosis (HP:0002612) | 1.82332030 |
| 156 | Agitation (HP:0000713) | 1.79712805 |
| 157 | Tubulointerstitial fibrosis (HP:0005576) | 1.79676924 |
| 158 | Abnormality of the costochondral junction (HP:0000919) | 1.79185258 |
| 159 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.78000710 |
| 160 | Enlarged epiphyses (HP:0010580) | 1.77892779 |
| 161 | Metaphyseal cupping (HP:0003021) | 1.77183878 |
| 162 | Bilateral microphthalmos (HP:0007633) | 1.76254083 |
| 163 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.76018684 |
| 164 | Short tibia (HP:0005736) | 1.76015862 |
| 165 | Cerebellar dysplasia (HP:0007033) | 1.75792282 |
| 166 | Prolonged neonatal jaundice (HP:0006579) | 1.75600329 |
| 167 | Abnormality of B cell number (HP:0010975) | 1.74427977 |
| 168 | Decreased circulating renin level (HP:0003351) | 1.74132609 |
| 169 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.74039130 |
| 170 | Focal seizures (HP:0007359) | 1.73207177 |
| 171 | Genital tract atresia (HP:0001827) | 1.72570417 |
| 172 | Vaginal atresia (HP:0000148) | 1.71862057 |
| 173 | Adrenal overactivity (HP:0002717) | 1.70061556 |
| 174 | Tubular atrophy (HP:0000092) | 1.69857482 |
| 175 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.67300470 |
| 176 | Malnutrition (HP:0004395) | 1.63511567 |
| 177 | Glomerulosclerosis (HP:0000096) | 1.63384064 |
| 178 | Abnormal auditory evoked potentials (HP:0006958) | 1.63345662 |
| 179 | Parakeratosis (HP:0001036) | 1.63082741 |
| 180 | Abnormality of serum amino acid levels (HP:0003112) | 1.62730411 |
| 181 | Increased serum pyruvate (HP:0003542) | 1.62518029 |
| 182 | Abnormality of glycolysis (HP:0004366) | 1.62518029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 8.08095485 |
| 2 | OXSR1 | 7.35938375 |
| 3 | STK39 | 6.41734644 |
| 4 | WNK3 | 5.36493929 |
| 5 | FRK | 4.25356630 |
| 6 | MAP4K2 | 3.26580503 |
| 7 | NUAK1 | 2.49943481 |
| 8 | WNK1 | 2.42945893 |
| 9 | BLK | 2.36803232 |
| 10 | ZAK | 2.30005137 |
| 11 | TLK1 | 2.05782854 |
| 12 | MAPK13 | 1.99058890 |
| 13 | EPHB1 | 1.92544212 |
| 14 | VRK2 | 1.78226799 |
| 15 | BCKDK | 1.71378152 |
| 16 | CASK | 1.69582404 |
| 17 | TAOK3 | 1.67994879 |
| 18 | SGK223 | 1.65062514 |
| 19 | SGK494 | 1.65062514 |
| 20 | PLK4 | 1.62234207 |
| 21 | MST4 | 1.60213185 |
| 22 | MAP3K4 | 1.46724615 |
| 23 | PKN1 | 1.44367084 |
| 24 | DAPK2 | 1.41623110 |
| 25 | ACVR1B | 1.41141356 |
| 26 | TAF1 | 1.34398350 |
| 27 | TGFBR1 | 1.31807384 |
| 28 | ADRBK1 | 1.26521939 |
| 29 | PRKCG | 1.23754204 |
| 30 | PRKCI | 1.20311546 |
| 31 | STK38L | 1.17533455 |
| 32 | PBK | 1.10184321 |
| 33 | PLK2 | 1.10069771 |
| 34 | PDK4 | 1.05853847 |
| 35 | PDK3 | 1.05853847 |
| 36 | MET | 1.03940196 |
| 37 | INSRR | 1.03636463 |
| 38 | VRK1 | 1.03575017 |
| 39 | DYRK2 | 0.99709112 |
| 40 | TNIK | 0.97256800 |
| 41 | BCR | 0.95482240 |
| 42 | PNCK | 0.93711099 |
| 43 | MAP2K7 | 0.93253640 |
| 44 | PDK2 | 0.89749118 |
| 45 | WEE1 | 0.88875007 |
| 46 | NEK6 | 0.83233180 |
| 47 | MST1R | 0.79458801 |
| 48 | EIF2AK2 | 0.76928784 |
| 49 | MAPK15 | 0.76547980 |
| 50 | TXK | 0.74098375 |
| 51 | GSK3A | 0.72320423 |
| 52 | MAPKAPK5 | 0.67510069 |
| 53 | IRAK1 | 0.67167684 |
| 54 | MKNK2 | 0.66982301 |
| 55 | EPHA4 | 0.65375021 |
| 56 | BRSK2 | 0.64865896 |
| 57 | NTRK1 | 0.63932281 |
| 58 | PAK3 | 0.63746133 |
| 59 | CCNB1 | 0.63329733 |
| 60 | ROCK2 | 0.63057630 |
| 61 | CAMK2B | 0.62821841 |
| 62 | TRPM7 | 0.62626352 |
| 63 | CSNK1G1 | 0.62451328 |
| 64 | STK3 | 0.62385209 |
| 65 | NLK | 0.61908923 |
| 66 | IRAK2 | 0.61044737 |
| 67 | SGK1 | 0.60521262 |
| 68 | CSNK1A1L | 0.59009198 |
| 69 | CAMKK2 | 0.58426156 |
| 70 | PDPK1 | 0.57974294 |
| 71 | DYRK3 | 0.56588630 |
| 72 | FGR | 0.56274504 |
| 73 | ERBB3 | 0.55727990 |
| 74 | PINK1 | 0.54234332 |
| 75 | STK24 | 0.54173282 |
| 76 | PRKAA2 | 0.52967966 |
| 77 | MAP3K14 | 0.52613010 |
| 78 | PRKCQ | 0.52117649 |
| 79 | CHEK2 | 0.50605430 |
| 80 | STK38 | 0.50485021 |
| 81 | NTRK3 | 0.50455595 |
| 82 | CSNK1G3 | 0.49749084 |
| 83 | FLT3 | 0.49031305 |
| 84 | GRK1 | 0.48370776 |
| 85 | OBSCN | 0.48097534 |
| 86 | PLK3 | 0.47465400 |
| 87 | FGFR2 | 0.46910292 |
| 88 | CSNK1G2 | 0.46682560 |
| 89 | CDK19 | 0.45940289 |
| 90 | FER | 0.45129376 |
| 91 | MAPKAPK3 | 0.45116490 |
| 92 | KIT | 0.44443802 |
| 93 | PLK1 | 0.44081824 |
| 94 | MAP2K2 | 0.43561498 |
| 95 | IKBKB | 0.43242364 |
| 96 | PTK2 | 0.43237172 |
| 97 | ERBB4 | 0.43209189 |
| 98 | GRK5 | 0.43099964 |
| 99 | CAMK1G | 0.42735292 |
| 100 | STK11 | 0.42652310 |
| 101 | CLK1 | 0.42156596 |
| 102 | PRKAA1 | 0.40966141 |
| 103 | PRKCE | 0.40534989 |
| 104 | CSNK1A1 | 0.40359702 |
| 105 | MAP3K7 | 0.39939071 |
| 106 | MAP3K13 | 0.38677662 |
| 107 | PRKD2 | 0.38661243 |
| 108 | TIE1 | 0.38110781 |
| 109 | MARK2 | 0.37200147 |
| 110 | MAP2K1 | 0.36981713 |
| 111 | GRK7 | 0.36688354 |
| 112 | CSNK1D | 0.36490647 |
| 113 | EIF2AK3 | 0.36369515 |
| 114 | CAMK2A | 0.36354205 |
| 115 | TRIM28 | 0.36196321 |
| 116 | CAMK2D | 0.35674666 |
| 117 | MAP2K6 | 0.35305918 |
| 118 | SGK2 | 0.34487608 |
| 119 | ABL2 | 0.34437375 |
| 120 | UHMK1 | 0.34428849 |
| 121 | CAMK2G | 0.32739332 |
| 122 | ADRBK2 | 0.32508071 |
| 123 | MKNK1 | 0.32258888 |
| 124 | SYK | 0.31607725 |
| 125 | PDK1 | 0.30283982 |
| 126 | PRKACA | 0.30236152 |
| 127 | PIK3CA | 0.30216845 |
| 128 | CDK5 | 0.29748532 |
| 129 | PRKD1 | 0.29554787 |
| 130 | PAK6 | 0.29242001 |
| 131 | FYN | 0.28064674 |
| 132 | TEC | 0.27753691 |
| 133 | BMPR1B | 0.27550727 |
| 134 | LIMK1 | 0.26176419 |
| 135 | GRK6 | 0.25809476 |
| 136 | PTK2B | 0.25495566 |
| 137 | FES | 0.24843240 |
| 138 | CHUK | 0.24482970 |
| 139 | PRKACB | 0.24208583 |
| 140 | INSR | 0.23784799 |
| 141 | NME1 | 0.23716149 |
| 142 | DYRK1A | 0.23610896 |
| 143 | MUSK | 0.23595667 |
| 144 | PHKG1 | 0.22724033 |
| 145 | PHKG2 | 0.22724033 |
| 146 | MARK1 | 0.21037866 |
| 147 | FGFR4 | 0.20427888 |
| 148 | CSK | 0.20251897 |
| 149 | ROCK1 | 0.20154568 |
| 150 | PRKCA | 0.19397717 |
| 151 | PRKCZ | 0.19006328 |
| 152 | STK16 | 0.18659757 |
| 153 | SGK3 | 0.18113369 |
| 154 | MAPK12 | 0.17450156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 4.35646354 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 4.08792748 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.16627891 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.97736382 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.87895045 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.73789835 |
| 7 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.71378797 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.68002069 |
| 9 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.61204966 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.48122066 |
| 11 | Peroxisome_Homo sapiens_hsa04146 | 2.36907991 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.26011679 |
| 13 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.18214432 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.13200551 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.12050840 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.11000120 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 2.07359480 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.00069127 |
| 19 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.96444739 |
| 20 | Nicotine addiction_Homo sapiens_hsa05033 | 1.91356975 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.87329539 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.85646021 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85635265 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.84623189 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.82781219 |
| 26 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.81018454 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.80272168 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74463549 |
| 29 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.68169015 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65756681 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.63001980 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.52663869 |
| 33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.47816925 |
| 34 | RNA polymerase_Homo sapiens_hsa03020 | 1.46837235 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.44110230 |
| 36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.37594296 |
| 37 | Mineral absorption_Homo sapiens_hsa04978 | 1.37144290 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.35968632 |
| 39 | Protein export_Homo sapiens_hsa03060 | 1.31570513 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 1.31106790 |
| 41 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.29930959 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.29364980 |
| 43 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.29361163 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.27566476 |
| 45 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.27480905 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.24344860 |
| 47 | RNA degradation_Homo sapiens_hsa03018 | 1.14447970 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.12830733 |
| 49 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.07221050 |
| 50 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05985105 |
| 51 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.05938652 |
| 52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.04410304 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.96924271 |
| 54 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.96539713 |
| 55 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.95210991 |
| 56 | Insulin secretion_Homo sapiens_hsa04911 | 0.94190935 |
| 57 | Circadian entrainment_Homo sapiens_hsa04713 | 0.92939449 |
| 58 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92796585 |
| 59 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.92449502 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89656740 |
| 61 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.89093882 |
| 62 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.88899146 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88847154 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.88774632 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88202691 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87669034 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.85738070 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82679619 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.81311841 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.80102931 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.79361320 |
| 72 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.77162456 |
| 73 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75483985 |
| 74 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.75370127 |
| 75 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.73876417 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.73241076 |
| 77 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.72692701 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.71684382 |
| 79 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.71478767 |
| 80 | Parkinsons disease_Homo sapiens_hsa05012 | 0.71363587 |
| 81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71053200 |
| 82 | Purine metabolism_Homo sapiens_hsa00230 | 0.67852378 |
| 83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66182094 |
| 84 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.65978360 |
| 85 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65187010 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.62750762 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62146172 |
| 88 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61954558 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.58690747 |
| 90 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57799364 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57711524 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57592373 |
| 93 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56735768 |
| 94 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.54485515 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52675132 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52101836 |
| 97 | Alzheimers disease_Homo sapiens_hsa05010 | 0.51961205 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51697943 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51535541 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48363495 |
| 101 | Asthma_Homo sapiens_hsa05310 | 0.47558674 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45912485 |
| 103 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45121610 |
| 104 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43460254 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42967697 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42707794 |
| 107 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.41788347 |
| 108 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41613572 |
| 109 | Long-term depression_Homo sapiens_hsa04730 | 0.41433776 |
| 110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39678963 |
| 111 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39274326 |
| 112 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.39224152 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38181761 |
| 114 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38134055 |
| 115 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.37372618 |
| 116 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36980695 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35385021 |
| 118 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.33764346 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33698069 |
| 120 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.33103149 |
| 121 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.30591087 |
| 122 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.30562502 |
| 123 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.28646771 |
| 124 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.25598082 |
| 125 | Axon guidance_Homo sapiens_hsa04360 | 0.23416792 |
| 126 | Salivary secretion_Homo sapiens_hsa04970 | 0.22571258 |
| 127 | ABC transporters_Homo sapiens_hsa02010 | 0.21873387 |
| 128 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.21703822 |
| 129 | GABAergic synapse_Homo sapiens_hsa04727 | 0.21191492 |
| 130 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19414417 |
| 131 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18977085 |
| 132 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.18944778 |
| 133 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.18091697 |
| 134 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.17502085 |
| 135 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.16844970 |
| 136 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.16805790 |
| 137 | Huntingtons disease_Homo sapiens_hsa05016 | 0.16247606 |
| 138 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.13315691 |
| 139 | Taste transduction_Homo sapiens_hsa04742 | 0.11094098 |
| 140 | Phototransduction_Homo sapiens_hsa04744 | 0.10653600 |

